These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

449 related items for PubMed ID: 18505468

  • 1. Exercise training improves autonomic function and inflammatory pattern in women with polycystic ovary syndrome (PCOS).
    Giallauria F, Palomba S, Maresca L, Vuolo L, Tafuri D, Lombardi G, Colao A, Vigorito C, Francesco O.
    Clin Endocrinol (Oxf); 2008 Nov; 69(5):792-8. PubMed ID: 18505468
    [Abstract] [Full Text] [Related]

  • 2. Metabolic and cardiopulmonary effects of detraining after a structured exercise training programme in young PCOS women.
    Orio F, Giallauria F, Palomba S, Manguso F, Orio M, Tafuri D, Lombardi G, Carmina E, Colao A, Vigorito C.
    Clin Endocrinol (Oxf); 2008 Jun; 68(6):976-81. PubMed ID: 17980005
    [Abstract] [Full Text] [Related]

  • 3. Comparison of aerobic exercise capacity and muscle strength in overweight women with and without polycystic ovary syndrome.
    Thomson RL, Buckley JD, Moran LJ, Noakes M, Clifton PM, Norman RJ, Brinkworth GD.
    BJOG; 2009 Aug; 116(9):1242-50. PubMed ID: 19438498
    [Abstract] [Full Text] [Related]

  • 4. Beneficial effects of a three-month structured exercise training program on cardiopulmonary functional capacity in young women with polycystic ovary syndrome.
    Vigorito C, Giallauria F, Palomba S, Cascella T, Manguso F, Lucci R, De Lorenzo A, Tafuri D, Lombardi G, Colao A, Orio F.
    J Clin Endocrinol Metab; 2007 Apr; 92(4):1379-84. PubMed ID: 17264174
    [Abstract] [Full Text] [Related]

  • 5. Chronic inflammation and elevated homocysteine levels are associated with increased body mass index in women with polycystic ovary syndrome.
    Guzelmeric K, Alkan N, Pirimoglu M, Unal O, Turan C.
    Gynecol Endocrinol; 2007 Sep; 23(9):505-10. PubMed ID: 17852421
    [Abstract] [Full Text] [Related]

  • 6. Altered autonomic neural control of the cardiovascular system in patients with polycystic ovary syndrome.
    Tekin G, Tekin A, Kiliçarslan EB, Haydardedeoğlu B, Katircibaşi T, Koçum T, Erol T, Cölkesen Y, Sezgin AT, Müderrisoğlu H.
    Int J Cardiol; 2008 Oct 30; 130(1):49-55. PubMed ID: 18055040
    [Abstract] [Full Text] [Related]

  • 7. Effect of long-term orlistat treatment on serum levels of advanced glycation end-products in women with polycystic ovary syndrome.
    Diamanti-Kandarakis E, Katsikis I, Piperi C, Alexandraki K, Panidis D.
    Clin Endocrinol (Oxf); 2007 Jan 30; 66(1):103-9. PubMed ID: 17201808
    [Abstract] [Full Text] [Related]

  • 8. The impact of intensified exercise training on insulin resistance and fitness in overweight and obese women with and without polycystic ovary syndrome.
    Harrison CL, Stepto NK, Hutchison SK, Teede HJ.
    Clin Endocrinol (Oxf); 2012 Mar 30; 76(3):351-7. PubMed ID: 21711376
    [Abstract] [Full Text] [Related]

  • 9. Comparison of the effects of atorvastatin and simvastatin in women with polycystic ovary syndrome: A prospective, randomized study.
    Kaya C, Pabuccu R, Cengiz SD, Dünder I.
    Exp Clin Endocrinol Diabetes; 2010 Mar 30; 118(3):161-6. PubMed ID: 20146169
    [Abstract] [Full Text] [Related]

  • 10. The evaluation of metabolic parameters and insulin sensitivity for a more robust diagnosis of the polycystic ovary syndrome.
    Amato MC, Galluzzo A, Finocchiaro S, Criscimanna A, Giordano C.
    Clin Endocrinol (Oxf); 2008 Jul 30; 69(1):52-60. PubMed ID: 18034780
    [Abstract] [Full Text] [Related]

  • 11. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
    Hassa H, Tanir HM, Yildiz Z.
    Arch Gynecol Obstet; 2006 Jul 30; 274(4):227-32. PubMed ID: 16691383
    [Abstract] [Full Text] [Related]

  • 12. Differences in low-grade chronic inflammation and insulin resistance in women with previous gestational diabetes mellitus and women with polycystic ovary syndrome.
    Thomann R, Rossinelli N, Keller U, Tirri BF, De Geyter C, Ruiz J, Kränzlin M, Puder JJ.
    Gynecol Endocrinol; 2008 Apr 30; 24(4):199-206. PubMed ID: 18382906
    [Abstract] [Full Text] [Related]

  • 13. Clinical and biochemical characteristics of polycystic ovary syndrome in Korean women.
    Chae SJ, Kim JJ, Choi YM, Hwang KR, Jee BC, Ku SY, Suh CS, Kim SH, Kim JG, Moon SY.
    Hum Reprod; 2008 Aug 30; 23(8):1924-31. PubMed ID: 18579512
    [Abstract] [Full Text] [Related]

  • 14. Abnormal heart rate recovery after maximal cardiopulmonary exercise stress testing in young overweight women with polycystic ovary syndrome.
    Giallauria F, Palomba S, Manguso F, Vitelli A, Maresca L, Tafuri D, Lombardi G, Colao A, Vigorito C, Orio F.
    Clin Endocrinol (Oxf); 2008 Jan 30; 68(1):88-93. PubMed ID: 17803701
    [Abstract] [Full Text] [Related]

  • 15. Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome.
    Wu J, Zhu Y, Jiang Y, Cao Y.
    Gynecol Endocrinol; 2008 Jul 30; 24(7):392-8. PubMed ID: 18608522
    [Abstract] [Full Text] [Related]

  • 16. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.
    Shi Y, Guo M, Yan J, Sun W, Zhang X, Geng L, Xu L, Chen Z.
    Neuro Endocrinol Lett; 2007 Dec 30; 28(6):807-10. PubMed ID: 18063948
    [Abstract] [Full Text] [Related]

  • 17. Effect of rosiglitazone on insulin resistance, growth factors, and reproductive disturbances in women with polycystic ovary syndrome.
    Belli SH, Graffigna MN, Oneto A, Otero P, Schurman L, Levalle OA.
    Fertil Steril; 2004 Mar 30; 81(3):624-9. PubMed ID: 15037412
    [Abstract] [Full Text] [Related]

  • 18. Cardiovascular risk in women with polycystic ovary syndrome.
    Giallauria F, Orio F, Palomba S, Lombardi G, Colao A, Vigorito C.
    J Cardiovasc Med (Hagerstown); 2008 Oct 30; 9(10):987-92. PubMed ID: 18799960
    [Abstract] [Full Text] [Related]

  • 19. Increased serum advanced glycation end-products is a distinct finding in lean women with polycystic ovary syndrome (PCOS).
    Diamanti-Kandarakis E, Katsikis I, Piperi C, Kandaraki E, Piouka A, Papavassiliou AG, Panidis D.
    Clin Endocrinol (Oxf); 2008 Oct 30; 69(4):634-41. PubMed ID: 18363886
    [Abstract] [Full Text] [Related]

  • 20. Body fat composition and distribution in women with polycystic ovary syndrome.
    Cosar E, Uçok K, Akgün L, Köken G, Sahin FK, Arioz DT, Baş O.
    Gynecol Endocrinol; 2008 Aug 30; 24(8):428-32. PubMed ID: 18850379
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.